• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆代谢分析揭示帕金森病中短链脂肪酸代谢的失调

Plasma Metabolic Analysis Reveals the Dysregulation of Short-Chain Fatty Acid Metabolism in Parkinson's Disease.

作者信息

Qi Ao, Liu Lulu, Zhang Junjie, Chen Simei, Xu Simin, Chen Yusen, Zhang Lijiang, Cai Chun

机构信息

Southern Marine Science and Engineering Guangdong Laboratory, Zhanjiang, 524023, Guangdong, China.

The First DongGuan Affiliated Hospital of Guangdong Medical University, Dongguan, 523475, Guangdong, China.

出版信息

Mol Neurobiol. 2023 May;60(5):2619-2631. doi: 10.1007/s12035-022-03157-y. Epub 2023 Jan 24.

DOI:10.1007/s12035-022-03157-y
PMID:36690885
Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disorder, characterized by high morbidity, high disability rate, and slow course of disease. The clinical diagnostic method of PD is complex and time-consuming, and there is no clear biomarker for clinical use. We aimed to investigate the plasma metabolites in PD and find out potential biomarkers with diagnostic ability. In the analysis of more than 40 metabolites including short-chain fatty acids, long-chain fatty acids, amino acids, and carbohydrates, the difference of short-chain fatty acids was observed. Acetic acid concentration was higher in PD than in healthy controls, and propanoic acid and 2,3,4-trihydroxybutyric acid were lower in PD. Compared with the early stage of PD, acetic acid increased significantly in the advanced stage of PD. Propanoic acid increased significantly in medicated PD compared with drug naïve PD. ROC analysis revealed acetic acid discriminated PD from healthy controls with 100% sensitivity, 88.9% specificity, and an area under the curve (AUC) of 0.981, and propanoic acid discriminated PD from healthy controls with an AUC of 0.981, 100% sensitivity, and 94.4% specificity. Acetic acid and propanoic acid may be a potential biomarker for differentiating PD from health, and the propanoic acid was evaluated as the most potential diagnostic marker because of its extremely high sensitivity and specificity.

摘要

帕金森病(PD)是一种进行性神经退行性疾病,其特点是发病率高、致残率高且病程缓慢。PD的临床诊断方法复杂且耗时,目前尚无明确的临床可用生物标志物。我们旨在研究PD患者的血浆代谢物,找出具有诊断能力的潜在生物标志物。在对包括短链脂肪酸、长链脂肪酸、氨基酸和碳水化合物在内的40多种代谢物进行分析时,观察到了短链脂肪酸的差异。PD患者的乙酸浓度高于健康对照,而丙酸和2,3,4-三羟基丁酸在PD患者中较低。与PD早期相比,PD晚期的乙酸显著增加。与未用药的PD患者相比,用药的PD患者丙酸显著增加。ROC分析显示,乙酸区分PD与健康对照的灵敏度为100%,特异度为88.9%,曲线下面积(AUC)为0.981;丙酸区分PD与健康对照的AUC为0.981,灵敏度为100%,特异度为94.4%。乙酸和丙酸可能是区分PD与健康状态的潜在生物标志物,丙酸因其极高的灵敏度和特异度被评估为最具潜力的诊断标志物。

相似文献

1
Plasma Metabolic Analysis Reveals the Dysregulation of Short-Chain Fatty Acid Metabolism in Parkinson's Disease.血浆代谢分析揭示帕金森病中短链脂肪酸代谢的失调
Mol Neurobiol. 2023 May;60(5):2619-2631. doi: 10.1007/s12035-022-03157-y. Epub 2023 Jan 24.
2
Plasma Short-Chain Fatty Acids Differences in Multiple System Atrophy from Parkinson's Disease.血浆短链脂肪酸在多系统萎缩与帕金森病中的差异。
J Parkinsons Dis. 2021;11(3):1167-1176. doi: 10.3233/JPD-212604.
3
Comprehensive metabolic profiling of Parkinson's disease by liquid chromatography-mass spectrometry.采用液相色谱-质谱联用技术对帕金森病进行全面代谢组学分析。
Mol Neurodegener. 2021 Jan 23;16(1):4. doi: 10.1186/s13024-021-00425-8.
4
Quantitative metabolomics of saliva using proton NMR spectroscopy in patients with Parkinson's disease and healthy controls.使用质子核磁共振波谱技术对帕金森病患者和健康对照者唾液进行定量代谢组学分析。
Neurol Sci. 2020 May;41(5):1201-1210. doi: 10.1007/s10072-019-04143-4. Epub 2020 Jan 3.
5
Plasma Short-Chain Fatty Acids in Patients With Parkinson's Disease.帕金森病患者的血浆短链脂肪酸。
Mov Disord. 2020 Jun;35(6):1021-1027. doi: 10.1002/mds.28016. Epub 2020 Mar 10.
6
Metabolomics profiling reveals altered lipid metabolism and identifies a panel of lipid metabolites as biomarkers for Parkinson's disease related anxiety disorder.代谢组学分析揭示了脂质代谢的改变,并确定了一组脂质代谢物作为帕金森病相关焦虑障碍的生物标志物。
Neurosci Lett. 2021 Feb 6;745:135626. doi: 10.1016/j.neulet.2021.135626. Epub 2021 Jan 10.
7
Targeted fatty acid metabolomics to discover Parkinson's disease associated metabolic alteration.靶向脂肪酸代谢组学发现帕金森病相关代谢改变。
J Mass Spectrom. 2021 Oct;56(10):e4781. doi: 10.1002/jms.4781.
8
Alterations of Sphingolipid and Phospholipid Pathways and Ornithine Level in the Plasma as Biomarkers of Parkinson's Disease.血浆中神经酰胺和磷脂代谢途径及精氨酸水平的改变可作为帕金森病的生物标志物。
Cells. 2022 Jan 24;11(3):395. doi: 10.3390/cells11030395.
9
Review of Metabolomics-Based Biomarker Research for Parkinson's Disease.基于代谢组学的帕金森病生物标志物研究综述。
Mol Neurobiol. 2022 Feb;59(2):1041-1057. doi: 10.1007/s12035-021-02657-7. Epub 2021 Nov 26.
10
Lipid metabolic dysregulation is involved in Parkinson's disease dementia.脂代谢失调与帕金森病痴呆有关。
Metab Brain Dis. 2021 Mar;36(3):463-470. doi: 10.1007/s11011-020-00665-5. Epub 2021 Jan 12.

引用本文的文献

1
Short-chain fatty acids mediate enteric and central nervous system homeostasis in Parkinson's disease: Innovative therapies and their translation.短链脂肪酸介导帕金森病中的肠道和中枢神经系统稳态:创新疗法及其转化。
Neural Regen Res. 2026 Mar 1;21(3):938-956. doi: 10.4103/NRR.NRR-D-24-01265. Epub 2025 Apr 29.
2
Association between plasma short-chain fatty acids and inflammation in human immunodeficiency virus-associated neurocognitive disorder: a pilot study.血浆短链脂肪酸与人类免疫缺陷病毒相关神经认知障碍炎症之间的关联:一项初步研究。
Lipids Health Dis. 2025 Feb 21;24(1):66. doi: 10.1186/s12944-025-02477-x.
3

本文引用的文献

1
Blood neuroexosomal excitatory amino acid transporter-2 is associated with cognitive decline in Parkinson's disease with RBD.血液神经外泌体兴奋性氨基酸转运体-2与伴快速眼动睡眠行为障碍的帕金森病认知功能下降有关。
Front Aging Neurosci. 2022 Aug 23;14:952368. doi: 10.3389/fnagi.2022.952368. eCollection 2022.
2
Association of Fecal and Plasma Levels of Short-Chain Fatty Acids With Gut Microbiota and Clinical Severity in Patients With Parkinson Disease.短链脂肪酸的粪便和血浆水平与帕金森病患者的肠道微生物群和临床严重程度的关联。
Neurology. 2022 Feb 22;98(8):e848-e858. doi: 10.1212/WNL.0000000000013225. Epub 2022 Jan 7.
3
Metabolism and metabolomics in senescence, aging, and age-related diseases: a multiscale perspective.
衰老、老化及年龄相关疾病中的代谢与代谢组学:多尺度视角
Front Med. 2025 Apr;19(2):200-225. doi: 10.1007/s11684-024-1116-0. Epub 2025 Jan 17.
4
Metabolic Dysfunction in Parkinson's Disease: Unraveling the Glucose-Lipid Connection.帕金森病中的代谢功能障碍:揭示葡萄糖 - 脂质关联
Biomedicines. 2024 Dec 13;12(12):2841. doi: 10.3390/biomedicines12122841.
5
The role of gut-derived short-chain fatty acids in Parkinson's disease.肠道来源的短链脂肪酸在帕金森病中的作用。
Neurogenetics. 2024 Oct;25(4):307-336. doi: 10.1007/s10048-024-00779-3. Epub 2024 Sep 13.
6
A crazy trio in Parkinson's disease: metabolism alteration, α-synuclein aggregation, and oxidative stress.帕金森病中的“疯狂三联征”:代谢改变、α-突触核蛋白聚集与氧化应激。
Mol Cell Biochem. 2025 Jan;480(1):139-157. doi: 10.1007/s11010-024-04985-3. Epub 2024 Apr 16.
7
Relationship Between Short-chain Fatty Acids and Parkinson's Disease: A Review from Pathology to Clinic.短链脂肪酸与帕金森病的关系:从病理学到临床的综述。
Neurosci Bull. 2024 Apr;40(4):500-516. doi: 10.1007/s12264-023-01123-9. Epub 2023 Sep 27.
Identification of cerebrospinal fluid biomarkers for parkinsonism using a proteomics approach.
采用蛋白质组学方法鉴定帕金森综合征的脑脊液生物标志物。
NPJ Parkinsons Dis. 2021 Nov 30;7(1):107. doi: 10.1038/s41531-021-00249-9.
4
Targeted fatty acid metabolomics to discover Parkinson's disease associated metabolic alteration.靶向脂肪酸代谢组学发现帕金森病相关代谢改变。
J Mass Spectrom. 2021 Oct;56(10):e4781. doi: 10.1002/jms.4781.
5
Plasma Short-Chain Fatty Acids Differences in Multiple System Atrophy from Parkinson's Disease.血浆短链脂肪酸在多系统萎缩与帕金森病中的差异。
J Parkinsons Dis. 2021;11(3):1167-1176. doi: 10.3233/JPD-212604.
6
Challenges in the diagnosis of Parkinson's disease.帕金森病诊断中的挑战。
Lancet Neurol. 2021 May;20(5):385-397. doi: 10.1016/S1474-4422(21)00030-2.
7
Parkinson's disease.帕金森病。
Lancet. 2021 Jun 12;397(10291):2284-2303. doi: 10.1016/S0140-6736(21)00218-X. Epub 2021 Apr 10.
8
Microbial Regulation of Host Physiology by Short-chain Fatty Acids.短链脂肪酸对宿主生理学的微生物调节作用。
Trends Microbiol. 2021 Aug;29(8):700-712. doi: 10.1016/j.tim.2021.02.001. Epub 2021 Mar 2.
9
Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study.通过 RT-QuIC 在孤立性快速眼动睡眠行为障碍患者的 CSF 中检测 α-突触核蛋白:一项纵向观察性研究。
Lancet Neurol. 2021 Mar;20(3):203-212. doi: 10.1016/S1474-4422(20)30449-X.
10
Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson's disease.肠道微生物衍生的丙酸盐介导骨钙素对帕金森病小鼠模型的神经保护作用。
Microbiome. 2021 Jan 31;9(1):34. doi: 10.1186/s40168-020-00988-6.